Nanomedicine Market statistics and global Industry size 2023


No comments posted yet


Slide 1

Opportunity Analysis and Industry Forecast, 2016-2023 Nanomedicine Market Expected to Reach $261,063 Million by 2023

Slide 2

Market Segmentation By Application Drug Delivery Vaccines Diagnostic Imaging Regenerative Medicine By Modality Diagnostics Treatments By Indication Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases

Slide 3

Global Nanomedicine Market accounted for $111,912 million in 2016, and is anticipated to reach $261,063 million by 2023, registering a CAGR of 12.6% from 2017 to 2023. Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine uses nanoscale manipulation of materials to improve medicine delivery. Nanomedicine Actual Market Value

Slide 4

Key Findings of Nanomedicine Market The regenerative medicine segment is anticipated to grow at the highest CAGR of 13.8% during the forecast period. China occupied one-third share of the Asia-Pacific nanomedicine market in 2016, registering a CAGR of 14.3% from 2017 to 2023. The U.S. was the major shareholder in the North America nanomedicine market in 2016.

Slide 5

Make An Inquiry About Report:  Get PDF Sample of Advance Research @

Slide 6

SUBSCRIBE CHANNEL FOLLOW US Thank You! For More Details Visit us at

Summary: Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine. Get PDF Sample for Details @ The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

Tags: nanomedicine market size in asia products on the statistics industry journal article types application